Next-Gen Strategies in Breast Cancer: HER2-Low ADCs and Post-CDK4/6 Sequencing in HR+/HER2- BC
Автор: Breast Cancers Today
Загружено: 2025-08-04
Просмотров: 70
Sanjay Juneja, MD, moderates the breast cancer panel from the Oncology Forum 2025, featuring Dr. Stephanie Graff, of Brown University, and Dr. Maryam Lustberg, of Yale Cancer Center. This in-depth discussion explores the evolving role of antibody-drug conjugates ADCs, HER2-low and ultralow classification, sequencing strategies in metastatic disease, and emerging neoadjuvant and immunotherapy approaches. The panel also highlights real-world considerations in treatment selection and future directions in clinical trial design.
#breastcancer #oncologyforum #her2positive #asco25 #cancerresearch
Доступные форматы для скачивания:
Скачать видео mp4
-
Информация по загрузке: